Today: 9 June 2026
Planet Labs PBC (PL) Stock Today: December 22, 2025 News, Forecasts, and Analyst Takeaways After the Rally
22 December 2025
6 mins read

Planet Labs PBC (PL) Stock Today: December 22, 2025 News, Forecasts, and Analyst Takeaways After the Rally

Planet Labs PBC (NYSE: PL) is starting December 22, 2025 near record territory after a month of headline catalysts that blended three powerful themes investors can’t resist: defense demand, AI-enabled data, and improving financial momentum. In premarket trading, PL was quoted around $19.79 early Monday, after a $19.18 prior close—levels that keep the stock close to recent highs and firmly on traders’ radar.

Today’s conversation around Planet Labs stock is less about “What does the company do?” and more about “How far can this rerating go—and what fundamentals need to show up next to justify it?”

Why Planet Labs stock is in the spotlight on Dec. 22, 2025

Two of the most-circulated angles in today’s coverage are:

  • Valuation after a sharp run-up. A December 22 analysis piece framed PL’s move as a “turnaround” for shareholders, noting the stock is up roughly 72% over the past month and nearly 59% over the past three months, raising the inevitable question: is the market getting ahead of itself? Simply Wall St
  • A broader “defense-growth” narrative. A Bloomberg markets newsletter dated December 22 grouped Planet Labs with a set of defense- and security-adjacent names that investors are increasingly treating like growth stocks rather than old-school contractors. Bloomberg

That macro framing matters because Planet is increasingly discussed as geospatial intelligence infrastructure—a category that sits at the intersection of national security, supply chains, climate monitoring, and AI.

What Planet Labs actually does (and why it matters for PL stock)

Planet Labs provides near-daily Earth imagery and geospatial solutions, operating what it describes as a fleet of approximately 200 Earth imaging satellites. The business sells data subscriptions and analytics that help customers spot change on Earth—fast—across sectors like government, agriculture, forestry, mapping, and more.

For stock investors, that translates into a simple investment debate:

  • If Planet becomes a default layer of “reality data” for governments and enterprises, recurring revenue can scale like software.
  • If the market commoditizes imagery or budgets tighten, the company risks becoming a capital-intensive data supplier with limited pricing power.

December’s newsflow pushed the market toward the more optimistic interpretation.

The earnings catalyst: Planet’s Q3 FY2026 results and raised outlook

The core driver behind PL’s December momentum was the company’s third-quarter fiscal year 2026 earnings release (quarter ended Oct. 31, 2025, reported Dec. 10, 2025). Planet reported:

  • Revenue of $81.3 million, up 33% year over year (record quarterly revenue)
  • Recurring annual contract value (ACV) at 97% for the quarter
  • Gross margin of 57% (non-GAAP gross margin 60%)
  • Adjusted EBITDA of $5.6 million profit, versus a small loss in the year-ago quarter
  • A third consecutive quarter of positive free cash flow, with year-to-date free cash flow of $55.2 million

Balance sheet commentary also stood out. Planet said it raised $460 million of convertible debt and ended the quarter with approximately $677.3 million in cash, cash equivalents, and short-term investments.

Management’s forecast: Q4 FY2026 and full-year FY2026 guidance

The company’s own forward outlook (the most important “forecast” for many long-term investors) includes:

Q4 FY2026 (ending Jan. 31, 2026):

  • Revenue expected $76 million to $80 million
  • Non-GAAP gross margin ~50% to 52%
  • Adjusted EBITDA loss ~($7) million to ($5) million
  • Capex ~$22 million to $26 million

Full fiscal year FY2026:

  • Revenue expected $297 million to $301 million
  • Non-GAAP gross margin ~57% to 58%
  • Adjusted EBITDA profit ~$6 million to $8 million
  • Capex ~$81 million to $85 million

One nuance investors are chewing on: the company is forecasting full-year adjusted EBITDA profitability, but expects a Q4 adjusted EBITDA loss—a reminder that the path to “software-like” earnings can still be lumpy for a satellite business.

The backlog signal: contracted future revenue is growing

Planet also disclosed expanding contracted coverage through:

  • Remaining performance obligations (RPO) of $672.470 million (as of Oct. 31, 2025)
  • Backlog of $734.471 million (as of Oct. 31, 2025)

The company indicated it expects to recognize about 33% of RPO within 12 months and 59% within 24 months (with the remainder later).

For PL stock bulls, this supports the narrative that Planet is landing more multi-year, repeatable work—particularly on the government and defense side.

The technology catalyst: Pelican satellites and “AI at the edge”

On the product side, Planet’s recent updates centered on its next-generation Pelican constellation.

In a December 9 release, Planet published “first light” imagery from Pelican‑6, with key details including:

  • The image was taken Dec. 4, 2025, from an altitude of ~519 km
  • Pelican‑5 and Pelican‑6 launched on Nov. 28, 2025 on SpaceX’s Falcon 9 Transporter‑15 mission, alongside 36 SuperDoves
  • The satellites include NVIDIA Jetson AI chips for on-orbit edge computing
  • Current Pelican generation supports Planet’s 50 cm products, while next-generation Pelicans are designed for 30 cm-class imagery

This matters for the stock because higher resolution + faster tasking + on-orbit compute can improve the value of Planet’s data for defense and time-sensitive monitoring, potentially supporting higher contract sizes and stickier renewals.

Defense and intelligence demand is becoming the PL stock storyline

Planet’s December rally didn’t happen in a vacuum. The company has been stacking contract-related announcements that reinforce a shift toward defense and intelligence as a major growth lane.

Examples from recent releases and coverage include:

  • An “8‑figure” contract renewal with a longstanding international defense and intelligence customer for high-resolution imagery, including access to Pelican and SkySat assured tasking capabilities. Business Wire
  • A $12.8 million award from the U.S. National Geospatial‑Intelligence Agency (NGA) under the Luno B IDIQ program for AI-enabled maritime domain awareness solutions.
  • Reuters previously reported Planet’s $230 million agreement to build high-resolution Pelican satellites for an Asia-Pacific commercial partner over seven years, with delivery slated for 2026—highlighting demand for “sovereign” or priority-access capabilities. Reuters

Put together, these moves help explain why Planet is increasingly mentioned in the same breath as “defense-tech” growth names in market commentary. Bloomberg

Analyst forecasts: where Wall Street price targets sit now

After the earnings beat and guidance raise, multiple firms and market trackers reported upward revisions to Planet Labs stock price targets.

A few notable datapoints circulating in December:

  • Needham raised its PL price target to $22 from $16, maintaining a Buy rating (as reported by Investing.com).
  • A MarketBeat roundup noted Morgan Stanley raising its target to $20 and Citigroup initiating at $19 with a “buy,” while also describing a “Moderate Buy” consensus (MarketBeat aggregates analyst data and notes). MarketBeat+1
  • Fintel’s analyst summary (as of Dec. 21) showed an average one-year price target of $17.78, with targets spanning roughly $11.11 to $23.10—a wide range that underscores disagreement about how durable Planet’s new growth narrative will be.

Why price targets are messy right now

When a stock moves this quickly, consensus targets often lag reality in two ways:

  1. Older targets stay in the data (dragging averages down), even as a few firms rush to update upward.
  2. Analysts differ on what Planet “should” be valued like—a data subscription platform (higher multiples) or an aerospace/imagery provider (lower multiples).

That valuation identity crisis is one of the biggest near-term drivers of volatility.

Valuation debate on Dec. 22: the market is paying for a new story

The most prominent “today” angle is valuation: after a steep climb, how much optimism is already priced in?

A December 22 valuation-focused writeup framed PL as having delivered a dramatic shareholder turnaround, flagging the speed of the move as the key issue for new buyers.

Meanwhile, Trefis analysis attributed much of PL’s last-12-month surge to multiple expansion, not just revenue growth. In its decomposition from Dec. 21, 2024 to Dec. 21, 2025, Trefis estimated:

  • Stock price rose from $4.04 to $19.18 (+374.75%)
  • Revenue rose from roughly $241.65M to $282.46M (LTM basis)
  • The P/S multiple increased from ~4.90 to ~21.00

Multiple expansion is not inherently “bad”—it’s what happens when markets decide a business has improved quality, visibility, or growth prospects. But it does raise the bar: to keep the stock supported at a higher valuation, investors will want to see continued execution on guidance, contract wins, and sustainable cash generation.

A volatility factor investors should not ignore: short interest

Planet Labs stock has also been associated with higher short interest, which can amplify both rallies and pullbacks.

MarketBeat data cited short interest around 29.89 million shares, about 11.77% of the float (as of a late-November reporting date), with a short interest ratio near 2.61 days.

High short interest doesn’t automatically mean a “squeeze,” but it can make price action sharper—especially around earnings, major contract announcements, or large intraday moves.

What to watch next for Planet Labs stock

With the quarter ending January 31, 2026, the next major fundamental checkpoint will be Planet’s Q4 and full-year FY2026 results—specifically whether the company can deliver on:

  • Revenue growth within the guided $76M–$80M Q4 range and $297M–$301M full-year range
  • Maintaining healthy non-GAAP gross margins, even with the guided Q4 step-down (50%–52%)
  • Continuing the streak of free cash flow discipline, which has become central to the bull case
  • Additional evidence that Pelican’s higher-resolution roadmap and on-orbit compute can translate into premium contracts and durable renewals

Bottom line for Dec. 22, 2025: PL stock is priced for execution

As of December 22, Planet Labs sits in a rare market niche: space infrastructure that behaves like an information business, with real traction in defense and intelligence spending cycles. The company’s latest results show faster revenue growth, improved adjusted EBITDA performance, expanding contracted coverage, and a balance sheet reinforced by convertible financing.

But the same thing powering PL stock—an aggressive rerating—also increases the risk of sharp pullbacks if growth slows, margins disappoint, or the contract narrative cools. For investors, the next chapter is less about whether Planet can build satellites (it can) and more about whether it can keep converting orbital capability into repeatable, high-margin, cash-generating demand—at a pace fast enough to justify today’s valuation.

Stock Market Today

  • Wheat Futures Rise as Export Inspections Show Mixed Data
    June 9, 2026, 9:19 AM EDT. Wheat futures gained on Monday, with Chicago SRW up 5-7 cents, KC HRW up 9-11 cents, and MPLS spring wheat rising slightly. Export inspections reported 319,730 MT shipped in the week ending June 4, down 20.65% from the previous week and 1.38% below last year. Mexico led exports with 83,211 MT. Managed money increased net shorts in Chicago wheat futures to 57,871 contracts, hitting a record bear move since 2006. Ukraine's wheat crop estimate rose 1.8 MMT to 21.7 MMT. July 26 CBOT Wheat futures closed at $5.86 ½, up 6 ½ cents, reflecting bullish momentum amid volatile trading conditions.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Bitfarms Stock (BITF) in Focus on Dec. 22, 2025: S&P/TSX Composite Addition, AI Data Center Pivot, and Updated Analyst Forecasts
Previous Story

Bitfarms Stock (BITF) in Focus on Dec. 22, 2025: S&P/TSX Composite Addition, AI Data Center Pivot, and Updated Analyst Forecasts

Tesla Stock (TSLA) News & Forecast — Dec. 22, 2025: Musk Pay Deal Restored, Robotaxi Testing Accelerates, and Wall Street Splits on 2026
Next Story

Tesla Stock (TSLA) News & Forecast — Dec. 22, 2025: Musk Pay Deal Restored, Robotaxi Testing Accelerates, and Wall Street Splits on 2026

Go toTop